MENINGIOMAS

Clinical trials for MENINGIOMAS explained in plain language.

Never miss a new study

Get alerted when new MENINGIOMAS trials appear

Sign up with your email to follow new studies for MENINGIOMAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Immunotherapy duo takes on Hard-to-Treat brain tumors

Disease control Ongoing

This study tests two immunotherapy drugs, nivolumab alone or combined with ipilimumab, in 40 adults with recurrent or progressive meningioma (a type of brain tumor). The goal is to see if these treatments can stop the tumor from growing for at least six months. Participants must …

Matched conditions: MENINGIOMAS

Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control

Last updated May 17, 2026 08:48 UTC

MENINGIOMAS

Get alerted when new MENINGIOMAS trials appear

Immunotherapy duo takes on Hard-to-Treat brain tumors